{"disease":{"id":"ulcerative-colitis-in-remission","name":"Ulcerative colitis in remission","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":2,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"mesalazine","indication_name":"Ulcerative colitis in remission","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rowasa","generic_name":"Mesalazine","company_name":"Meda Pharms","drug_phase":"marketed","molecular_target":"Prostaglandin G/H synthase 2","drug_class":"Aminosalicylate [EPC]","quality_score":65,"revenue":null,"mechanism":"Rowasa works by blocking the production of prostaglandins, which are chemicals that cause inflammation in the rectum and colon."},{"drug_id":"mesa","indication_name":"Ulcerative colitis in remission","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"MESA","company_name":"Meda Pharms","drug_phase":"marketed","molecular_target":"Arachidonate 5-lipoxygenase, Peroxisome proliferator-activated receptor gamma, Prostaglandin G/H synthase 1","drug_class":"","quality_score":38,"revenue":null,"mechanism":""}],"pipeline":[],"offLabel":[],"totalMarketed":2,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06372613","title":"Association Between LRG and Histologic Remission in Ulcerative Colitis","phase":"","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Showa Inan General Hospital","has_results":false},{"nct_id":"NCT06642883","title":"Evaluation of ProLife 10 FORTE on Gut Microbiota Composition in UC Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"University of Padova","has_results":false},{"nct_id":"NCT03501758","title":"Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound","phase":"","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Haukeland University Hospital","has_results":false},{"nct_id":"NCT05656391","title":"Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative Colitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta","has_results":false},{"nct_id":"NCT03122613","title":"Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis","phase":"NA","overall_status":"TERMINATED","enrollment_count":29,"lead_sponsor_name":"Chinese University of Hong Kong","has_results":false},{"nct_id":"NCT05202990","title":"Oral Fecal Microbiota Transplantation in Pediatric Ulcerative Colitis","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":26,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06576700","title":"Effect of Procyanidins in Leaky Gut Repairing in IBD","phase":"NA","overall_status":"RECRUITING","enrollment_count":25,"lead_sponsor_name":"University of Padova","has_results":false},{"nct_id":"NCT03698812","title":"A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis","phase":"","overall_status":"UNKNOWN","enrollment_count":9,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}